Phase II Study of Cobimetinib in Combination With Vemurafenib in Active Melanoma Brain Metastases
Clinical trial NCT02230306 · TERMINATED
Trial details
- NCT number
- NCT02230306
- Sponsor
- Melissa Burgess, MD
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2016-03-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.